Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multicentric Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02419742
What this trial is testing

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

Who this might be right for
Breast Cancer
Hoffmann-La Roche 110
Post-approval studies (Phase 4)UnknownNCT01908556
What this trial is testing

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

Who this might be right for
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
Institut fuer Frauengesundheit 3,545
Not applicableActive Not RecruitingNCT05942092
What this trial is testing

ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques.

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 1,400
Not applicableStudy completedNCT04999917
What this trial is testing

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer InvasiveBreast Cancer in Situ
XEOS Medical 206
Not applicableEnrolling By InvitationNCT06843096
What this trial is testing

Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

Who this might be right for
Breast Cancer DiagnosisBreast Cancer Prevention
Graziella di Grezia 350
Large-scale testing (Phase 3)UnknownNCT02831426
What this trial is testing

Pre-pectoral Breast Reconstruction PART 2

Who this might be right for
Breast Cancer
Guy's and St Thomas' NHS Foundation Trust 86
Large-scale testing (Phase 3)Active Not RecruitingNCT01805271
What this trial is testing

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Who this might be right for
Primary Non-metastatic Breast CancerWho Remain Disease-free
UNICANCER 1,278
Not applicableUnknownNCT04656639
What this trial is testing

Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer

Who this might be right for
Breast Cancer
Seoul National University Hospital 580
Not applicableLooking for participantsNCT05933876
What this trial is testing

The Impact of Radiotherapy on Oligometastatic Cancer

Who this might be right for
MetastasisMetastatic Breast CancerMetastatic Prostate Cancer+2 more
Institut Investigacio Sanitaria Pere Virgili 2,000
Large-scale testing (Phase 3)Active Not RecruitingNCT02089100
What this trial is testing

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 154
Not applicableActive Not RecruitingNCT05942105
What this trial is testing

Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 1,064
Not applicableStudy completedNCT02393287
What this trial is testing

Retroprospective Real Life Observatory of Eribulin

Who this might be right for
Metastatic Breast Cancer
Institut Cancerologie de l'Ouest 753
Not applicableLooking for participantsNCT05378204
What this trial is testing

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Institut Claudius Regaud 120
Testing effectiveness (Phase 2)Study completedNCT05545150
What this trial is testing

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Bilateral Breast CarcinomaBreast Ductal Carcinoma In Situ+3 more
Northwestern University 113
Not applicableLooking for participantsNCT06415266
What this trial is testing

Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 264
Large-scale testing (Phase 3)UnknownNCT04300829
What this trial is testing

Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients

Who this might be right for
Breast AdenocarcinomaRadiation DermatitisRadiation Toxicity
Centre Leon Berard 248
Not applicableStudy completedNCT02056886
What this trial is testing

Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer

Who this might be right for
Breast CancerSurgery
Institut Cancerologie de l'Ouest 858
Not applicableStudy completedNCT04253366
What this trial is testing

Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection

Who this might be right for
Breast Cancer
Umbria Bioengineering Technologies 353
Not applicableStudy completedNCT06428799
What this trial is testing

Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment

Who this might be right for
Breast CancerBreast Tumor Benign
Carebot s.r.o. 122
Not applicableLooking for participantsNCT06970275
What this trial is testing

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

Who this might be right for
Prostate CancersBreast CancerHead and Neck Cancer+1 more
XEOS Medical 850
Next Page